PriceTargets.com logo

Babylon - BBLN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $53.08
  • Forecasted Upside: 756.18%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$6.20 As of 03/24/2023 01:00 AM ET
▼ -0.41 (-6.20%)

This chart shows the closing price for BBLN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Babylon Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BBLN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BBLN

Analyst Price Target is $53.08
▲ +756.18% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Babylon in the last 3 months. The average price target is $53.08, with a high forecast of $137.50 and a low forecast of $11.00. The average price target represents a 756.18% upside from the last price of $6.20.

This chart shows the closing price for BBLN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 polled investment analysts is to hold stock in Babylon. This rating has held steady since December 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/16/2023BTIG ResearchDowngradeBuy ➝ NeutralLow
3/10/2023CitigroupLower Target$15.00 ➝ $11.00Low
1/5/2023BTIG ResearchBoost TargetBuy$20.00Low
11/11/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$100.00 ➝ $50.00Low
11/11/2022Canaccord Genuity GroupLower TargetBuy$100.00 ➝ $50.00Low
8/17/2022Canaccord Genuity GroupLower TargetBuy$125.00 ➝ $100.00Low
8/17/2022Canaccord Genuity GroupLower Target$125.00 ➝ $100.00Low
6/23/2022Bank of AmericaInitiated CoverageNeutral$50.00Low
5/16/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$200.00 ➝ $125.00High
5/13/2022CitigroupLower Target$125.00 ➝ $37.50High
4/28/2022Berenberg BankInitiated CoverageHold$137.50High
4/25/2022BTIG ResearchLower Target$375.00 ➝ $250.00High
3/11/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$350.00 ➝ $200.00Low
1/12/2022Deutsche Bank AktiengesellschaftInitiated CoverageBuy$225.00High
12/7/2021CitigroupInitiated CoverageNeutral$200.00High
12/1/2021Jefferies Financial GroupInitiated CoverageHold$225.00Medium
11/17/2021BTIG ResearchInitiated CoverageBuy$375.00Low
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.11 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
Mentions as of
8/28/2022
  • 5 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 5 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 2 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 2 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Babylon logo
Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $6.20
Low: $6.11
High: $6.65

50 Day Range

MA: $9.90
Low: $5.89
High: $13.06

52 Week Range

Now: $6.20
Low: $5.75
High: $104.00

Volume

31,850 shs

Average Volume

48,268 shs

Market Capitalization

$154.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Babylon?

The following sell-side analysts have issued research reports on Babylon in the last year: Bank of America Co., Berenberg Bank, BTIG Research, Canaccord Genuity Group Inc., and Citigroup Inc..
View the latest analyst ratings for BBLN.

What is the current price target for Babylon?

6 Wall Street analysts have set twelve-month price targets for Babylon in the last year. Their average twelve-month price target is $53.08, suggesting a possible upside of 756.2%. Berenberg Bank has the highest price target set, predicting BBLN will reach $137.50 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $11.00 for Babylon in the next year.
View the latest price targets for BBLN.

What is the current consensus analyst rating for Babylon?

Babylon currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BBLN, but not buy more shares or sell existing shares.
View the latest ratings for BBLN.

What other companies compete with Babylon?

Other companies that are similar to Babylon include Reunion Neuroscience, Better Therapeutics, UpHealth, P3 Health Partners and Pear Therapeutics. Learn More about companies similar to Babylon.

How do I contact Babylon's investor relations team?

The company's listed phone number is 44-0-20-7100-0762 and its investor relations email address is [email protected] The official website for Babylon is www.babylonhealth.com. Learn More about contacing Babylon investor relations.